Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoko Obata

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
Journal of Nephrology|June 12, 2012
Recombinant human erythropoietin attenuates renal tubulointerstitial injury in murine adriamycin-induced nephropathyYuka Nakazawa, Tomoya Nishino, Yoko Obata, et al.
Clinical and Experimental Nephrology|January 9, 2020
Hexapeptide derived from prothymosin alpha attenuates cisplatin-induced acute kidney injuryKenta Torigoe, Yoko Obata, Miki Torigoe, et al.
Clinical Drug Investigation|September 27, 2013
The effect of active vitamin D administration on muscle mass in hemodialysis patientsAtsushi Mori, Tomoya Nishino, Yoko Obata, et al.
The International Journal of Artificial Organs|October 19, 2019
Endovascular therapy for hemodialysis patients with atrial fibrillation and cerebral thromboembolism: A case seriesMasafumi Kamijo, Waka Hayashi, Emiko Otsuka, et al.
Renal Failure|February 17, 2022
Association between fluid infusions and the recovery from acute kidney injury in patients administered liposomal amphotericin B: a nationwide observational studyMasato Tashiro, Yoko Obata, Takahiro Takazono, et al.
Clinical and Experimental Nephrology|November 12, 2020
The clinical usage of liposomal amphotericin B in patients receiving renal replacement therapy in Japan: a nationwide observational studyYoko Obata, Takahiro Takazono, Masato Tashiro, et al.
Acta Biomaterialia|April 11, 2012
HSP47 siRNA conjugated with cationized gelatin microspheres suppresses peritoneal fibrosis in miceYoko Obata, Tomoya Nishino, Toshihiro Kushibiki, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|October 4, 2012
22-Oxacalcitriol prevents progression of peritoneal fibrosis in a mouse modelMisaki Hirose, Tomoya Nishino, Yoko Obata, et al.
Renal Failure|May 9, 2012
Identification of a novel mutation and prevalence study for fabry disease in Japanese dialysis patientsTomoya Nishino, Yoko Obata, Akira Furusu, et al.
CEN Case Reports|September 1, 2017
A case of mild phenotype Alport syndrome caused by COL4A3 mutationsMasafumi Kamijo, Mineaki Kitamura, Kumiko Muta, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Journal of Nephrology|June 12, 2012
Recombinant human erythropoietin attenuates renal tubulointerstitial injury in murine adriamycin-induced nephropathyYuka Nakazawa, Tomoya Nishino, Yoko Obata, et al.
Clinical and Experimental Nephrology|January 9, 2020
Hexapeptide derived from prothymosin alpha attenuates cisplatin-induced acute kidney injuryKenta Torigoe, Yoko Obata, Miki Torigoe, et al.
Clinical Drug Investigation|September 27, 2013
The effect of active vitamin D administration on muscle mass in hemodialysis patientsAtsushi Mori, Tomoya Nishino, Yoko Obata, et al.
The International Journal of Artificial Organs|October 19, 2019
Endovascular therapy for hemodialysis patients with atrial fibrillation and cerebral thromboembolism: A case seriesMasafumi Kamijo, Waka Hayashi, Emiko Otsuka, et al.
Renal Failure|February 17, 2022
Association between fluid infusions and the recovery from acute kidney injury in patients administered liposomal amphotericin B: a nationwide observational studyMasato Tashiro, Yoko Obata, Takahiro Takazono, et al.
Clinical and Experimental Nephrology|November 12, 2020
The clinical usage of liposomal amphotericin B in patients receiving renal replacement therapy in Japan: a nationwide observational studyYoko Obata, Takahiro Takazono, Masato Tashiro, et al.
Acta Biomaterialia|April 11, 2012
HSP47 siRNA conjugated with cationized gelatin microspheres suppresses peritoneal fibrosis in miceYoko Obata, Tomoya Nishino, Toshihiro Kushibiki, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|October 4, 2012
22-Oxacalcitriol prevents progression of peritoneal fibrosis in a mouse modelMisaki Hirose, Tomoya Nishino, Yoko Obata, et al.
Renal Failure|May 9, 2012
Identification of a novel mutation and prevalence study for fabry disease in Japanese dialysis patientsTomoya Nishino, Yoko Obata, Akira Furusu, et al.
CEN Case Reports|September 1, 2017
A case of mild phenotype Alport syndrome caused by COL4A3 mutationsMasafumi Kamijo, Mineaki Kitamura, Kumiko Muta, et al.
Pageof 8